Maximum quantity allowed is 999
CAS RN: 330784-47-9 | Product Number: A3476
Avanafil

Purity: >98.0%(T)(HPLC)
- TA-1790
- (S)-4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
1G |
₹3,800.00
|
Contact Us | 37 |
|
5G |
₹12,200.00
|
Contact Us | 21 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | A3476 |
Purity / Analysis Method ![]() |
>98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__2__3H__2__6ClN__7O__3 = 483.96 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Air Sensitive,Heat Sensitive |
CAS RN | 330784-47-9 |
Reaxys Registry Number | 11746013 |
MDL Number | MFCD11977961 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Melting point | 163.0 to 167.0 °C |
Specific rotation | -62.0 to -72.0 deg (C=1, methanol) |
NMR | confirm to structure |
Melting Point | 165 °C |
References
- Avanafil, a Potent and Highly Selective Phosphodiesterase-5 Inhibitor for Erectile Dysfunction
- PDE5 inhibitors: considerations for preference and long-term adherence (a review)
- Development and validation of RP-HPLC method for simultaneous estimation of avanafil and dapoxentine hydrochloride in bulk and dosage form
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.